How Human-Led, AI-Powered systems designed specifically for healthcare turn data overload into decision-ready insight. Healthcare marketers are flooded with data, from patient conversations and HCP feedback to social listening, CRM activity, and market signals, yet actionable insights remain difficult to uncover. This eBook explores why generic AI often falls short in healthcare and shows how a Human-Led, AI-Powered approach can turn complex data into trusted, decision-ready intelligence.
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Every protocol decision affects patients, and only those with lived disease experience can identify true burden — from invasive biopsies to daily trial demands.
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parexel’s Stacy Hurt on how patients’ use of AI is reshaping sponsor communication.
Pfizer and Blackstone Life Sciences sign a co-funding deal in which Blackstone is set to provide up to $1.5 billion through 2028 to advance berobenatide.
